Compare Quant Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
-
5.0
Min SIP Amount
₹1000
₹100
Expense Ratio
2.42
1.87
NAV
₹14.44
₹37.61
Fund Started
27 Jun 2023
25 Jun 2018
Fund Size
₹350.44 Cr
₹6801.16 Cr
Exit Load
Exit load of 1%, if redeemed within 15 days.
Exit load of 1% if redeemed within 15 days.
1 Year
7.44%
8.17%
3 Year
-
27.53%
5 Year
-
16.59%
Equity
96.34%
97.98%
Cash
-15.48%
1.99%
Top 10 Holdings
Viyash Scientific Limited | 8.83% |
Zydus Wellness Ltd. | 8.45% |
SMS Pharmaceuticals Ltd. | 8.44% |
Aurobindo Pharma Ltd. | 7.71% |
Aster DM Healthcare Ltd. | 7.24% |
Alivus Life Sciences Ltd | 6.95% |
Pfizer Ltd. | 6.43% |
Adani Enterprises Ltd. | 6.16% |
Anthem Biosciences Ltd. | 5.87% |
ICICI Bank Ltd. | 4.79% |
Sun Pharmaceutical Industries Ltd. | 11.21% |
Cipla Ltd. | 9.40% |
Mankind Pharma Ltd. | 7.64% |
Dr. Reddy's Laboratories Ltd. | 6.52% |
Biocon Ltd. | 6.20% |
Divi's Laboratories Ltd. | 5.95% |
Lupin Ltd. | 3.99% |
Aurobindo Pharma Ltd. | 3.70% |
Alkem Laboratories Ltd. | 3.47% |
Syngene International Ltd. | 3.16% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
27 Jun 2023
25 Jun 2018
